ID-IRC : 2111150599
OULDIM Karim
Professeur d’enseignement supérieur
Spécialité : Génétique
Faculté de Médecine et de Pharmacie de Fès
CHU Hassan II de Fès-Hôpital des Spécialités
Domaine de Maîtrise :
Biopathologie et Recherche Biomédicale
Domaine d’intérêt :
Nouvelles Technologies - Ingénierie - Systèmes d’Information et IA
Les publications :
1. Molecular and presymptomatic analysis of a Moroccan Lynch syndrome family revealed a novel frameshift MLH1 germline mutation. Moufid FZ, Bouguenouch L, El Bouchikhi I, Houssaini MI, Ouldim K. Turk J Gastroenterol. 2018 Nov;29(6):701-704. doi: 10.5152/tjg.2018.17761.
2. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence. Moufid FZ, Bouguenouch L, El Bouchikhi I, Chbani L, Iraqui Houssaini M, Sekal M, Belhassan K, Bennani B, Ouldim K. Genet Test Mol Biomarkers. 2018 Aug;22(8):492-497. doi: 10.1089/gtmb.2018.0067. Epub 2018 Jul 25.
3. [Fanconi anemia at the University Hospital (CHU) Hassan II of Fez: about 6 cases]. Bouguenouch L, Samri I, Abbassi M, Hamdaoui H, Otmani IE, Sayel H, Trhanint S, Benmiloud S, Amrani M, Bennis S, Ouldim K, Hida M. Pan Afr Med J. 2017 Dec 4;28:286. doi: 10.11604/pamj.2017.28.286.4372. eCollection 2017. French.
4. Gut microbiome of Moroccan colorectal cancer patients. Allali I, Boukhatem N, Bouguenouch L, Hardi H, Boudouaya HA, Cadenas MB, Ouldim K, Amzazi S, Azcarate-Peril MA, Ghazal H. Med Microbiol Immunol. 2018 Aug;207(3-4):211-225. doi: 10.1007/s00430-018-0542-5. Epub 2018 Apr 23.
5. High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control. Laarabi FZ, Ratbi I, Elalaoui SC, Mezzouar L, Doubaj Y, Bouguenouch L, Ouldim K, Benjaafar N, Sefiani A. BMC Res Notes. 2017 Jun 2;10(1):188. doi: 10.1186/s13104-017-2511-2.
6. Genetics and genomic medicine in Morocco: the present hope can make the future bright. Belhassan K, Ouldim K, Sefiani AA. Mol Genet Genomic Med. 2016 Nov 10;4(6):588-598. eCollection 2016 Nov.
7. [Lynch syndrome: case report and review of the literature].Bouguenouch L, Samri I, Belhassan K, Sayel H, Abbassi M, Bennis S, Benajah DA, Ibrahimi A, Amarti A, Ouldim K.Pan Afr Med J. 2016 Jun 14;24:142. doi: 10.11604/pamj.2016.24.142.4398. eCollection 2016. Review. French.
8. Epigenetics could explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway exploration.Sekal M, Ameurtesse H, Chbani L, Ouldim K, Bennis S, Abkari M, Boulouz A, Benajah DA, Benjelloun B, Ousadden A, Ait Taleb K, Ait Laalim S, Toghrai I, Mazaz K, Arifi S, Mellas N, El Rhazi K, Harmouch T, Ibrahimi SA, Amarti Riffi A.Diagn Pathol. 2015 Jun 24;10:77. doi: 10.1186/s13000-015-0326-9.
9. Improving medical research in the Arab world. El-Azami-El-Idrissi M, Lakhdar-Idrissi M, Ouldim K, Bono W, Amarti-Riffi A, Hida M, Nejjari C.Lancet. 2013 Dec 21;382(9910):2066-7. doi: 10.1016/S0140-6736(13)62692-6. No abstract available.
10. [Pharmacogenetics: what about Morocco?]. Idrissi MJ, Ouldim K, Amarti A, El Hassouni M, Khabbal Y. Pan Afr Med J. 2013 Apr 10;14:143. doi: 10.11604/pamj.2013.14.143.2141. Print 2013. Review. French. No abstract available.
11. The first mutations in the MYH gene reported in Moroccan colon cancer patients. Laarabi FZ, Cherkaoui Jaouad I, Baert-Desurmont S, Ouldim K, Ibrahimi A, Kanouni N, Frebourg T, Sefiani A. Gene. 2012 Mar 15;496(1):55-8. doi: 10.1016/j.gene.2011.12.024. Epub 2012 Jan 10.
12. Genetic testing and first presymptomatic diagnosis in Moroccan families at high risk for breast/ovarian cancer.Laarabi FZ, Jaouad IC, Ouldim K, Aboussair N, Jalil A, Gueddari BE, Benjaafar N, Sefiani A. Oncol Lett. 2011 Mar;2(2):389-393. Epub 2011 Jan 21.
13. Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences. Chalabi N, Bernard-Gallon DJ, Bignon YJ; Breast Med Consortium, Kwiatkowski F, Agier M, Vidal V, Laplace-Chabaud V, Sylvain-Vidal V, Bertholet V, De Longueville F, Lacroix M, Leclercq G, Remacle J, Sibille C, Zammateo N, Ben Jaafar N, Sefiani A, Ouldim K, Mégarbané K, Jalkh N, Mahfoudh W, Troudi W, Ben Ammar-El Gaïed A, Chouchane L. Cancer Genomics Proteomics. 2008 Sep-Oct;5(5):253-61. Erratum in: Cancer Genomics Proteomics. 2008 Nov-Dec;5(6):353. Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):73.